About 900 reports

  • IMMUNOLOGY, GLOBAL, LICENSING DEALS, 2006-2017
  • IMMUNOLOGY, GLOBAL, CO-DEVELOPMENT DEALS, 2006-2017

Only one JAK inhibitor, Xeljanz, is approved for the immunology market.

  • Targeted Therapy
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Some of these biologics are approved and used in more than one conditions.

  • Medical Biotechnology
  • Targeted Therapy
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Psoriasis Market by Segment, U. S., 2014 – 2024 (US

  • Anti Rheumatic
  • Targeted Therapy
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ulcerative Colitis Market by Segment, U. S., 2014 –

  • Medical Biotechnology
  • Targeted Therapy
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ankylosing Spondylitis Market by Segment, U. S., ##

  • Anti Rheumatic
  • Targeted Therapy
  • Therapy
  • United States
  • World

Some of these biologics are approved and used in more than one conditions.

  • Medical Biotechnology
  • Targeted Therapy
  • Therapy
  • United States
  • Market Size

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Rheumatoid Arthritis Market by Segment, U. S., 2014

  • Anti Rheumatic
  • Medical Biotechnology
  • Targeted Therapy
  • Therapy
  • United States

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Crohn’s Disease Market by Segment, U. S., 2014 – ##

  • Autoimmune Disease
  • Pathology
  • Targeted Therapy
  • Therapy
  • United States

Immunology – Market size and forecast 2017-2022 • Hematology – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by application PART ##: MARKET SEGMENTATION BY ORIGIN OF MONOCLONAL ANTIBODIES • Segmentation by origin of monoclonal antibodi

  • Medical Biotechnology
  • Targeted Therapy
  • Therapy
  • World
  • Market Size
  • RA Therapeutics Market, Global, All Pipeline Products, Discovery, 2016

Nature Reviews Immunology. ##(##): ##-##.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.

TINA HEALY, MSCI, IS THE SENIOR DIRECTOR FOR IMMUNOLOGY BASED IN LONDON, WHERE SHE MANAGES THE IMMUNOLOGY MARKET ANALYSIS AND FORECASTS PORTFOLIO AND THE IMMUNOLOGY COMPETITIVE INTELLIGENCE (CI) PORTFOLIO.

  • Targeted Therapy
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in monoclonal antibody dealmaking ##. ##.

  • Monoclonal Antibody
  • Pharmaceutical
  • Targeted Therapy
  • United States
  • Demand

IN TURN, THIS SHOULD ATTRACT COMMERCIAL STAKEHOLDERS INTERESTED IN THIS AREA OF IMMUNOLOGY.

  • Targeted Therapy
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • A) Oncology pipeline by molecular target
  • GLOBAL BIOSIMILAR PIPELINE BY THERAPY AREA AND MOLECULAR TARGET (1/2)

TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Targeted Therapy
  • Market Size
  • Supply
  • Remicade group
  • BOYCE JA (2003). MAST CELLS: BEYOND IGE. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY; 111: 24-32
  • PELAIA G, ET AL. (2012). THE POTENTIAL OF BIOLOGICS FOR THE TREATMENT OF ASTHMA. NATURE DRUG DISCOVERY; 11: 958-972

MUCOSAL IMMUNOLOGY; ##(##): ##-## WITHERS AL (2012).

  • Targeted Therapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.
  • of All Pipeline Products

Frontiers in Immunology; ##: ## Pfizer (2003).

  • Targeted Therapy
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.
  • IL inhibitors offer improved efficacy and safety profiles in comparison to anti-TNF inhibitors and other standards of care capturing increased market share across the immunology market
  • OF CONTENTS

Glucose levels and intraocular pressure are measured today, but just one measurement at a time in the doctor' s office.

  • Targeted Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

REV PRESS., ##(##), PP. ##-##.

  • Targeted Therapy
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.
  • THREATS
  • SHIRE'S DISEASE PORTFOLIO ASSESSMENT, 2018

NATURE REVIEWS IMMUNOLOGY; ##(##): ##-##.

  • Targeted Therapy
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group

Baxalta US Inc is a US-based company which develops medications in hematology, immunology and oncology.

  • Targeted Therapy
  • United States
  • World
  • AbbVie Inc.
  • Amgen Inc.

So you' ve got this one plus one equals two.

  • Targeted Therapy
  • East Asia
  • United States
  • Forecast
  • Pfizer Inc.

ET AL. (2013) ' UVEITIS WITH MYASTHENIA GRAVIS-A RARE ASSOCIATION', OCULAR IMMUNOLOGY AND INFLAMMATION, ##(##), PP. ##-##.

  • Targeted Therapy
  • Japan
  • United States
  • World
  • Forecast

IMMUNOLOGY, I AM ONLY HANDLING THE IMMUNOLOGY PORTFOLIO HERE.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MAB PIPELINE BY THERAPY AREA AND STAGE OF DEVELOPMENT
  • MAB PIPELINE BY MAB TYPE

Advances in Immunology; ##: ##-## Castellani RJ, et al. (1997).

  • Targeted Therapy
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson

Immunology sales increased, led by Xolair and Actemra/ RoActemra.

  • Targeted Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Prior to joining GlobalData as Director, she worked as an analyst in immunology and neurology and as a consultant for a boutique life sciences consulting firm in New York City.

  • Targeted Therapy
  • United States
  • Forecast
  • AstraZeneca PLC
  • Roche Group

IMMUNOLOGY, I AM ONLY HANDLING THE IMMUNOLOGY PORTFOLIO HERE.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 5.3 Clinical Trial Duration
  • 5.2.3 PATIENT ENROLLMENT PER TRIAL BY MOLECULE TYPE, MOLECULAR TARGET AND STAGE OF DEVELOPMENT

The Journal of Immunology; ##(##) ##. ## Bibliography Armstrong AW, et al. (2013).

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG

PFIZER BACKGROUND/ DERMATOLOGY BUSINESS STRUCTURE: PFIZER RANKS AMONG THE LEADING COMPANIES GLOBALLY/ ONE IN ' BIG PHARMA', OPERATING IN THERAPEUTIC AREAS OF CARDIOVASCULAR HEALTH, METABOLISM, ONCOLOGY, INFLAMMATION AND IMMUNOLOGY.

  • Targeted Therapy
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • RA Therapeutics Market, Global, All Pipeline Products, Discovery, 2016

Immunology; ##(##): ##-## Mori S, et al. (2010).

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Galapagos NV